Keyword: Genentech

The clinical success comes months before the FDA is set to decide whether to approve the survival motor neuron-2 splicing modifier.

Genentech veteran Frank Lee landed at Forma Therapeutics as it aimed to go from an early-stage company to one knocking on the door of approval.

Julie Grant is the fourth woman to join Canaan’s ranks of general partners. She joins Maha Ibrahim, Nina Kjellson and Wende Hutton.

A phase 1/2b test showed Roche's antibody mosunetuzumab can trigger durable responses in a significant minority of hard-to-treat NHL patients.

Micro cap anti-infective biotech Aridis Pharmaceuticals has gained a new chief medical officer in the form of former Takeda Vaccines exec Paul Mendelm

After a series of major exits from its C-suite including the exit of Chief Medical Officer Andrew Cheng last fall, Gilead now has a new CMO.

With new data exploring lung cancer biomarkers, Roche says that DNA blood tests could soon replace tissue biopsies for picking targeted treatments.

Takeda’s cytomegalovirus drug beat Roche’s Valcyte at clearing the virus in patients who had undergone an organ transplant or stem cell transplant.

Smaller biotechs are continuing their biopharma hiring spree as two startups nab some big names for their aspiring cancer drug research.

Opthea tested its drug in combination with Lucentis, finding that the combo bested Lucentis alone at improving vision and reducing scarring in the retina.